Skip to content
Dx

ICD-10-CM 2027 diagnosis code

S20.314SAbrasion of middle front wall of thorax, sequela

✓ Billable / specificPOA exemptRequires 7th character

S20.314S is a valid, billable ICD-10-CM code for abrasion of middle front wall of thorax, sequela. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code last changed in FY2021 (effective October 1, 2020). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About S20.314S

S20.314S is the ICD-10-CM diagnosis code for abrasion of middle front wall of thorax, sequela. It belongs to category S20 (superficial injury of thorax), block S20-S29 (injuries to the thorax) and chapter 19 (injury, poisoning and certain other consequences of external causes). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

The 7th character "S" means sequela: use it for complications or conditions that arise as a direct result of the original condition.

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 604 (Trauma to the Skin, Subcutaneous Tissue and Breast with MCC, relative weight 1.453) and DRG 605 (Trauma to the Skin, Subcutaneous Tissue and Breast without MCC, relative weight 0.9079), in MDC 09 (Diseases and Disorders of the Skin, Subcutaneous Tissue and Breast), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.

It was added in FY2021, effective October 1, 2020.

7th character

Ssequela

Other encounter types for S20.314:

Notes that apply from higher levels

Instructions written at a parent level also apply to S20.314S.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2021 (effective 10/1/2020): Added
  • No changes since FY2021.

Common questions about S20.314S

Is S20.314S billable?

Yes. S20.314S is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

What does the "S" at the end of S20.314S mean?

It is the 7th character for sequela. Per the official guidelines, use it for complications or conditions that arise as a direct result of the original condition.

Can S20.314S be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict S20.314S as a principal diagnosis.

Is S20.314S a CC or MCC?

No. S20.314S is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does S20.314S group to?

S20.314S is used in the MS-DRG v44.0 logic for MS-DRG 604 (Trauma to the Skin, Subcutaneous Tissue and Breast with MCC) and MS-DRG 605 (Trauma to the Skin, Subcutaneous Tissue and Breast without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.